生物型主动脉瓣结构性瓣膜衰败:被低估的并发症
术后1年起4年和7年SVD累积发生率分别为15.2%(95%CI 11.9-19.1)和31.0%(95%CI 25.8-37.2),女性、血脂异常、COPD和严重患者-人工瓣膜不匹配为显著危险因素,SVD与死亡风险增加2倍相关。
要点
- Mitroflow瓣术后7年SVD累积发生率达31.0%,应重视长期随访。
- 女性、血脂异常、COPD及严重患者-人工瓣膜不匹配增加SVD风险。
- SVD与死亡风险增加2倍相关,需采用合适统计模型避免低估。
核心结论
- 应采用合适的统计模型以避免低估SVD并发症及其与更差长期生存的关联。
主要发现
- 术后1年起4年和7年SVD累积发生率分别为15.2%(95%CI 11.9-19.1)和31.0%(95%CI 25.8-37.2)。
- 女性、血脂异常、慢性阻塞性肺疾病和严重患者-人工瓣膜不匹配是SVD的显著危险因素。
- SVD的发生与死亡风险增加2倍相关。
临床怎么用
- 对植入Mitroflow等生物瓣的患者应加强长期随访,关注SVD危险因素及生存影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Structural valve deterioration (SVD) remains a major bioprosthesis-related complication, as recently described for the Mitroflow valve (models LX and 12A) (LivaNova, London, United Kingdom). The real incidence of the SVD risk remains unclear, often due to methodologic pitfalls by systematically using the Kaplan-Meier estimator and/or the Cox model. In this report, we propose for the first time a precise statistical modeling of this issue. METHODS: Five hundred sixty-one patients who underwent aortic valve replacement with the aortic Mitroflow valve between 2002 and 2007 were included. We used an illness-death model for interval-censored data. Median follow-up was 6.6 years; 103 cases of SVD were diagnosed. RESULTS: The 4-year and 7-year SVD cumulative incidences after the first anniversary of surgery were 15.2% (95% confidence interval, 11.9-19.1) and 31.0% (95% confidence interval, 25.8-37.2), respectively. Female gender, dyslipidemia, chronic obstructive pulmonary disease, and severe patient-prosthesis mismatch were significant risk factors of SVD. The occurrence of SVD was associated with a 2-fold increase in the risk of death. CONCLUSIONS: Appropriate statistical models should be used to avoid underestimating the SVD complication associated with worse long-term survival.
引用
- Sénage T, Gillaizeau F, Le Tourneau T, et al. Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication. J Thorac Cardiovasc Surg. 2018. PMID: 30415900. doi:10.1016/j.jtcvs.2018.08.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。